MediPharm Labs Sets Date to Report Full Year and Fourth Quarter 2024 Financial Results

Stock Information for C21 Investments Inc - Ordinary Shares

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About C21 Investments Inc - Ordinary Shares

Leading Independent Proxy Advisor Glass Lewis Recommends Shareholders Vote the GREEN proxy FOR ALL MediPharm Director Nominees
MediPharm Reminds Shareholders to Vote in Advance of June 13 Deadline
MediPharm Announces Complete Dismissal of Dissident Court Proceeding Related to Annual and Special Meeting
Apollo Capital Releases Investor Presentation Highlighting Plan to Make MediPharm Labs the World's Leading International Medical Cannabis Company
MediPharm Labs' Founder-CEO Pat McCutcheon Throws his Support behind Apollo Capital as Dissident
MediPharm Labs Closes $4.5 Million Sale of Hope, BC Facility and Announces Plans to Expand EU GMP Cultivation Capacity at Napanee Facility
Leading Independent Proxy Advisor ISS Recommends that Shareholders Vote the GREEN proxy FOR ALL MediPharm Director Nominees; REJECTS Apollo's Arguments and Director Slate
MediPharm Labs Refuses to Answer Direct Questions Regarding Credible Securities Fraud Allegations Says Apollo Capital

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.